Formula: | C19H26N2O4S |
Molecular Weight: | 378.49 |
Rotatable Bond Donors: | 4 |
clogP: | 1.55 |
Topological Polar Surface Area: | 75.71 |
Lipinski's RO5: | MW: 378.49 HBA: 6 HBD: 1 RB: 4 LogP: 1.55 |
Rule of Three: | MW: 378.49 HBA: 6 HBD: 1 RB: 4 LogP: 1.55 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS18014 | 0.83 | EOS18014 RDKit 3D 27 30 0 0 0 0 0 0 0 0999 V2000 -7.0450 -1.0088 -0.9273 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0076 -0.0094 -1.3255 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9310 0.4634 -2.4527 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.1732 0.2965 -0.2755 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.1001 1.2399 -0.4476 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9356 0.6246 -1.1889 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8573 0.1979 -0.2212 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2360 -1.1234 0.4292 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0803 -1.6869 1.1912 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3163 -2.6616 2.1604 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2539 -3.2066 2.8759 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0463 -2.7793 2.6245 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2839 -1.8073 1.6557 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2274 -1.2546 0.9215 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4809 -0.1770 -0.1114 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8279 1.1183 0.6113 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2496 2.2049 -0.3520 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3533 1.7412 -1.1953 N 0 0 0 0 0 0 0 0 0 0 0 0 3.9257 1.9563 -0.6259 S 0 0 0 0 0 0 0 0 0 0 0 0 3.9879 3.2755 -0.0331 O 0 0 0 0 0 0 0 0 0 0 0 0 4.8269 1.5574 -1.6856 O 0 0 0 0 0 0 0 0 0 0 0 0 4.1401 0.7918 0.7629 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5854 0.7043 1.1520 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9501 -0.4056 0.3683 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0560 0.5156 -1.9441 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6465 -0.5906 -0.9982 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6517 0.0234 -0.9687 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 2 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 19 21 2 0 19 22 1 0 22 23 1 0 23 24 1 0 18 25 1 0 25 26 1 0 15 27 1 0 27 7 1 0 14 9 1 0 26 15 1 0 24 22 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |